biological source
mouse
antibody form
ascites fluid
antibody product type
primary antibodies
clone
3.1112G, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable, immunofluorescence: suitable, immunohistochemistry: suitable, western blot: suitable
isotype
IgM
shipped in
wet ice
Immunogen
Epitope: NS1
Application
Immunofluorescence: 1:2 to 1:50
EIA 1:20 to 1:200
Western Blot 1:20 to 1:200
Immunohistochemistry
Optimal working dilutions must be determined by the end user.
EIA 1:20 to 1:200
Western Blot 1:20 to 1:200
Immunohistochemistry
Optimal working dilutions must be determined by the end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-West Nile Virus/Kunjin Antibody, NS1, clone 3.1112G is validated for use in ELISA, IF, IH, WB for the detection of West Nile Virus/Kunjin.
Biochem/physiol Actions
Specific for the non-structural protein 1 of West Nile/Kunjin virus. Kunjin (KUN) is very closely related to some strains of West Nile virus, and has been classified as a subtype of West Nile.
Physical form
Ascites fluid with 0.1% sodium azide as a preservative.
Unpurified
Preparation Note
Maintain for 2 years at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Analysis Note
Control
West Nile Virus positive patient sample
West Nile Virus positive patient sample
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Still not finding the right product?
试用我们的 产品选型工具 工具缩小选择范围
存储类别
10 - Combustible liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
M Giel-Moloney et al.
Scientific reports, 9(1), 20005-20005 (2019-12-29)
Multiple approaches utilizing viral and DNA vectors have shown promise in the development of an effective vaccine against HIV. In this study, an alternative replication-defective flavivirus vector, RepliVax (RV), was evaluated for the delivery of HIV-1 immunogens. Recombinant RV-HIV viruses
B Durand et al.
Epidemiology and infection, 144(9), 1857-1864 (2016-02-04)
A serosurvey of 349 military working horses and 231 military working dogs was conducted in ten sites in Morocco in 2012. This survey revealed a high level of exposure of these animals to flaviviruses: seroprevalence rates of 60% in horses
Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness.
Melissa C Whiteman,Jason A Wicker,Richard M Kinney,Claire Y-H Huang,Tom Solomon,Alan D T Barrett
Vaccine null